APR 12, 2019 8:15 AM PDT

Pulmonary Hypertension in Sarcoidosis

WRITTEN BY: Dena Aruta

Sarcoidosis is an inflammatory disease that involves the formation of non-caseating granulomas, a cluster of macrophages, in response to a foreign substance or antigen in the body, They can be found in any organ system, but 90% of people diagnosed have it in their lungs. The granulomas (also called nodules) can be found in the interstitial tissues (around the air sacs), thoracic lymph nodes, and the vascular system of the lungs.

Pulmonary arterial hypertension (PAH) is increased pulmonary arterial pressure that is characterized by increased pulmonary vascular resistance that can lead to failure of the right ventricle of the heart. It can be life-threatening if not treated. PAH is seen as a complication in sarcoidosis from 5-28% of patients and at rates as high as 74% of those with advanced disease. Sarcoidosis-associated PAH has been shown to worsen its prognosis and may increase the risk of death 7-fold. 

Management of PAH in sarcoidosis is not well understood, and there are currently no specific treatments approved. Kishan Parikh and colleagues published the results of their study on patient characteristics, clinical outcomes, treatment, and management strategies of sarcoidosis-associated PAH  in the journal, Scientific Reports. They followed a large cohort of biopsy-proven sarcoidosis patients with PAH from Duke University for 11 years. "Our primary outcomes of interest were change in 6-minute walk distance (6MWD) and change in N-terminal pro-brain natriuretic peptide (NT-proBNP) by after therapy," states Dr. Parikh. 

Out of the 95 participants who met the criteria for the study, 70% had stage IV pulmonary sarcoidosis, and 77% had functional class III/IV symptoms (marked or severe activity limitations and comfortable only at rest). The median NT-proBNP value was elevated (910 pg/mL), and right ventricular dysfunction was moderate/severe in 55% of patients. The mortality rate over an average of three years was 32% with a mean time to hospitalization or death at six months. 

The authors report three major findings: (1) high morbidity that reflects the disease burden with both pulmonary hypertension and stage IV pulmonary sarcoidosis, (2) no change in the six-minute walk test with PAH-specific treatment, and (3) 37 patients receiving PAH-specific therapy had a 51% improvement in their NT-proBNP. 

In this lecture by Dr. Maddipati from the Division of Pulmonary and Critical Care Medicine at East Carolina University, he gives an overview of sarcoidosis-associated PAH and current treatment strategies. Ultimately, patients who are diagnosed with sarcoidosis-associated PAH should be evaluated for possible lung transplantation. 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
SEP 22, 2020
Space & Astronomy
Scientists Discover New Kind Planet- an Ultrahot Neptune
SEP 22, 2020
Scientists Discover New Kind Planet- an Ultrahot Neptune
Scientists have identified a new kind of planet- an ‘ultrahot Neptune’, or a giant exoplanet that orbits its ...
SEP 24, 2020
Health & Medicine
Pregnancy Cannabis Use Linked With Psychotic Behaviors in Offspring
SEP 24, 2020
Pregnancy Cannabis Use Linked With Psychotic Behaviors in Offspring
Women are already warned that using marijuana during pregnancy might affect their baby’s growth in the womb, but a ...
SEP 27, 2020
Cell & Molecular Biology
How Spiders May Open a Path to IBS Treatment
SEP 27, 2020
How Spiders May Open a Path to IBS Treatment
Irritable bowel syndrome (IBS) is term that describes a gut disorder that causes abdominal pain, cramping, diarrhea or c ...
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 05, 2020
Cancer
Does Having an Appendectomy Increase Your Risk for Cancer?
OCT 05, 2020
Does Having an Appendectomy Increase Your Risk for Cancer?
Cancer research is more than just the study of diagnostics and novel therapies. Researchers also investigate the causes ...
OCT 05, 2020
Earth & The Environment
The rising concern of aerosol particles
OCT 05, 2020
The rising concern of aerosol particles
A study from Colorado State University scientists provides insight into the resiliency of aerosol particles, particles f ...
Loading Comments...